Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 August 2004

Bone marrow transplantation in the course of hematological malignancies – Follow-up study in blood serum by 31P MRS

Małgorzata Kuliszkiewicz-Janus, Stanisław Baczyński, Anna Jurczyk

Med Sci Monit 2004; 10(8): CR485-492 :: ID: 11721

Abstract

Background:Bone marrow transplantation (BMT) is one of the most efficient methods for the treatment of hematological neoplasms. Its successful application requires previous complete remission (CR) and exclusion of residual disease.Material/Methods: This 31P MRS study reports data collected during several years of observation of nineteen patients. Duration of observation varied from 1 to 8.5 years from the time of diagnosis. Data collected after BMT covered periods ranging from 1.5 months to 6.5 years.Results: 31P MRS spectra of normal sera showed four peaks, that at the lowest field due to Pi and the other three to phospholipids (PL), i.e. phosphatidylethanolamine + sphingomyelin (PE + SM), lysophosphatidylcholine (LPC), and phosphatidylcholine (PC). Long-term follow-up studies showed good correlation between the [sup]31[/sup]P MR spectral features of sera and disease response to therapy. In particular, at the time of diagnosis spectra showed significant decreases in the levels of all detected phospholipids (PC, LPC, PE and SM). These decreases, dependent upon disease severity, changed during chemotherapy according to the individual response of the patient. During chemotherapy and after BMT, the spectral profile changed in responding patients to resemble that of normal serum with the typical, higher peak intensities.Conclusions: Longitudinal analysis of in vitro [sup]31[/sup]P spectra of sera of patients with hematological malignancies represents a reliable method to evaluate the susceptibility of the neoplasm to a cytostatic treatment. The same approach seems to be useful in evaluating the effectiveness and outcome of bone marrow transplantation over time.

Keywords: Phosphorus Isotopes - chemistry, Adolescent, Bone Marrow Transplantation, Follow-Up Studies, Hematologic Neoplasms - metabolism, Magnetic Resonance Spectroscopy - methods, Phospholipids - blood, Phosphorus Isotopes - chemistry

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750